![](/img/cover-not-exists.png)
155OEfficacy of TAS-120, an irreversible fibroblast growth factor receptor inhibitor (FGFRi), in patients with cholangiocarcinoma and FGFR pathway alterations previously treated with chemotherapy and other FGFRi’s
Tran, B, Meric-Bernstam, F, Arkenau, H-T, Bahleda, R, Kelley, R K, Hierro, C, Ahn, D, Zhu, A, Javle, M, Winkler, R, He, H, Huang, J, Goyal, LVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy432.007
Date:
November, 2018
File:
PDF, 86 KB
english, 2018